Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tractMichael Frumovitz, Aung Naing, Shannon N. Westin et al.|Gynecologic Oncology|2020Cited by 72